FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Healthcare & Life Sciences Enterprise Capital Monitor – USA – 05/2024”.
The Monitor is a month-to-month printed overview of enterprise capital developments within the US Healthcare & Life Sciences sector.
As of the top of Could 2024 we recognized the next present VC developments in the US:
- Complete Healthcare & Life Sciences funding reached EUR 15,114m
- Biotech obtained 56% of the full funding quantity (EUR 8,512m) with oncology being the main indication (28%)
- TechBio is likely one of the strongest development segments scoring 9% of the full YTD funding quantity
- In Mai Hercules CM secures the highest transaction quantity with EUR 373m, adopted by AltruBio with EUR 209m and Zenas BioPharma with EUR 187m
- ARCH Enterprise Companions (United States) is essentially the most energetic investor (by deal quantity), adopted by RA Capital Administration (United States) and GV (Google Ventures / United States)
To entry the complete report, please click on right here.
By Mathias Klozenbücher und Johannes Hyperlink.
